A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355

Clinical trial NCT03802162 · COMPLETED

Trial details

NCT number: NCT03802162
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease (AD)

Start date: 2019-02-15
Primary completion: 2019-05-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.